Recombinant Salmonella heidelberg Cobalt transport protein CbiN (cbiN)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant CbiN

Recombinant Salmonella Heidelberg Cobalt Transport Protein CbiN (UniProt ID: B4T8X4) is a bacterial membrane protein critical for cobalt uptake, a metal essential for bacterial metabolism, particularly in cobalamin (vitamin B12) biosynthesis . The protein is expressed as a recombinant product in E. coli with an N-terminal His-tag for purification .

Key Features

ParameterDetails
Source OrganismSalmonella Heidelberg (GenBank: B4T8X4)
Expression HostE. coli
Molecular Weight~10.2 kDa (1–93 amino acids)
Purity>90% (SDS-PAGE)
TagN-terminal His-tag
Storage BufferTris/PBS-based buffer (pH 8.0) with 6% trehalose
StabilitySensitive to repeated freeze-thaw cycles; store at -20°C/-80°C

Mechanistic Insights

The CbiMNQO system operates via an energy-coupling mechanism:

  1. Cobalt Binding: CbiM binds extracellular Co²⁺, while CbiN facilitates substrate capture .

  2. ATP Hydrolysis: CbiO (ATPase) couples energy from ATP to drive cobalt translocation .

  3. Subunit Interactions:

    • CbiM and CbiN form a dynamic complex with CbiQO, with CbiN weakly associating with the stable CbiMQO subcomplex .

    • CbiM stimulates ATPase activity of CbiO, independent of cobalt binding .

Cobalt Specificity

ParameterValue
Cobalt Uptake RateHigh (>90% efficiency)
Nickel Uptake RateLow (~8% of cobalt activity)
Substrate PreferenceCo²⁺ > Ni²⁺

Research Applications and Challenges

Biotechnological Uses

  • Cobalamin Biosynthesis: CbiN is critical for supplying cobalt to the cobalamin synthetic pathway, enabling bacterial production of B12 .

  • Protein Engineering: Recombinant CbiN is used to study ECF transporter dynamics and optimize cobalt-dependent metabolic pathways .

Production Challenges

  • Expression Optimization: Homogeneous expression in E. coli requires tuning mRNA accessibility near translation initiation sites to mitigate folding bottlenecks .

  • Stability Issues: Lyophilized CbiN requires aliquoting to prevent degradation during repeated freeze-thaw cycles .

Clinical and Pathogenic Relevance

While CbiN itself is not directly linked to virulence, cobalt transport systems impact bacterial survival in host environments:

  • Antibiotic Resistance: Cobalt uptake may influence biofilm formation and multidrug resistance (MDR) in Salmonella Heidelberg, though CbiN’s role remains unconfirmed .

  • Host Adaptation: Strains with elevated expression of flagellar/chemotaxis genes (e.g., SX 245) show enhanced invasion, suggesting nutrient acquisition systems like CbiMNQO may indirectly support pathogenicity .

Comparative Analysis with Other Transporters

FeatureCbiMNQO (Group I ECF)BtuB (Group II ECF)
SubstrateCo²⁺Cobalamin
ATPase ComponentCbiOBtuD
Substrate-BindingCbiM + CbiNBtuB (single component)
RegulationCobalamin riboswitchTonB-dependent signaling

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have a specific format requirement, please indicate it when placing your order. We will accommodate your request if possible.
Lead Time
Delivery time may vary depending on the purchasing method and location. For specific delivery timelines, please consult your local distributor.
Note: Our standard shipping method includes blue ice packs. If you require dry ice shipping, please inform us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal stability, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly prior to opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard final concentration of glycerol is 50%. Customers can use this as a reference point.
Shelf Life
Shelf life is influenced by various factors including storage conditions, buffer composition, temperature, and protein stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple use. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process.
We will determine the tag type during the production process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
cbiN; SeHA_C2244; Cobalt transport protein CbiN; Energy-coupling factor transporter probable substrate-capture protein CbiN
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-93
Protein Length
full length protein
Species
Salmonella heidelberg (strain SL476)
Target Names
cbiN
Target Protein Sequence
MKKTLMLLAMVVALVILPFFINHGGEYGGSDGEAESQIQAIAPQYKPWFQPLYEPASGEI ESLLFTLQGSLGAAVIFYILGYCKGKQRRDDRA
Uniprot No.

Target Background

Function
CbiN is a component of the energy-coupling factor (ECF) transporter complex CbiMNOQ, which is involved in cobalt import.
Database Links
Protein Families
CbiN family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the biological function of Cobalt transport protein CbiN in Salmonella heidelberg?

Cobalt transport protein CbiN functions as a component of the energy-coupling factor (ECF) transporter system in Salmonella heidelberg, specifically involved in cobalt uptake and transport across the bacterial membrane. The protein is part of the CbiMNQO transport system, where CbiN likely serves as a substrate-capture protein that facilitates the initial binding of cobalt ions .

As part of the bacterial vitamin B12 (cobalamin) biosynthetic pathway, CbiN plays a critical role in ensuring sufficient cobalt is available for incorporation into the corrin ring structure of cobalamin. This function is essential for numerous metabolic processes in Salmonella, including DNA synthesis and cellular energy production. The protein consists of 93 amino acids and contains characteristic transmembrane domains that anchor it to the bacterial membrane .

What expression systems are most effective for recombinant CbiN production?

Based on current research protocols, E. coli expression systems have proven most effective for recombinant CbiN production . When expressing the full-length protein (1-93 amino acids), an N-terminal His-tag fusion approach allows for efficient purification while maintaining protein functionality.

The typical expression protocol involves:

  • Cloning the cbiN gene from Salmonella heidelberg into an expression vector containing an N-terminal His-tag

  • Transforming the construct into an E. coli expression strain (commonly BL21(DE3) or derivatives)

  • Inducing protein expression using IPTG (isopropyl β-D-1-thiogalactopyranoside) or auto-induction media

  • Cell harvesting and lysis under native conditions

  • Purification using nickel affinity chromatography

For optimal expression, researchers should consider temperature control (typically 18-25°C for membrane proteins), induction time (4-16 hours), and appropriate antibiotic selection based on the expression vector .

What techniques are recommended for purification and storage of recombinant CbiN protein?

The purification and storage of recombinant CbiN requires specific techniques to maintain protein integrity:

Purification Protocol:

  • Centrifuge the bacterial lysate to remove cell debris

  • Apply the supernatant to a pre-equilibrated nickel affinity column

  • Wash with buffer containing low imidazole concentration

  • Elute the His-tagged CbiN with buffer containing high imidazole concentration (250-500 mM)

  • Perform buffer exchange to remove imidazole using dialysis or gel filtration

  • Verify purity using SDS-PAGE (>90% purity should be achievable)

Storage Recommendations:

  • Store the purified protein in Tris/PBS-based buffer with 6% trehalose at pH 8.0

  • Add glycerol to a final concentration of 50% for long-term storage

  • Aliquot the protein solution to avoid repeated freeze-thaw cycles

  • Store aliquots at -20°C or preferably -80°C

  • For working solutions, maintain at 4°C for up to one week

Repeated freeze-thaw cycles should be avoided as they can significantly impact protein stability and activity. For reconstitution, it is recommended to dissolve the lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL .

How can researchers optimize experimental designs for studying CbiN function in bacterial systems?

Optimizing experimental designs for studying CbiN function requires a systematic approach:

  • Control Selection: Include both positive controls (known functional cobalt transporters) and negative controls (transport-deficient mutants) in all experiments.

  • Growth Conditions: Use minimal media supplemented with defined cobalt concentrations to precisely control the experimental environment. Testing growth under cobalt-limited and cobalt-rich conditions can reveal functional aspects of the transport system.

  • Genetic Manipulation Approaches:

    • Gene knockout studies using CRISPR-Cas9 or homologous recombination

    • Complementation assays with wild-type and mutant variants

    • Site-directed mutagenesis to identify critical residues

  • Transport Assays: Implement isotope-labeled cobalt (⁵⁷Co or ⁶⁰Co) uptake assays to directly measure transport activity. Compare uptake rates between wild-type strains and cbiN mutants.

  • Interaction Studies: Use bacterial two-hybrid systems or co-immunoprecipitation to identify interaction partners within the cobalt transport complex.

A methodologically sound experimental design would incorporate multiple approaches to establish causality between CbiN and cobalt transport function, while controlling for confounding variables such as growth rate differences and expression levels .

What methodology can be used to measure the interaction between recombinant CbiN and other components of the cobalt transport system?

To effectively measure interactions between recombinant CbiN and other components of the cobalt transport system, researchers should employ multiple complementary methodologies:

In vitro Approaches:

  • Surface Plasmon Resonance (SPR): Immobilize purified His-tagged CbiN on a sensor chip and measure binding kinetics with other purified components (CbiM, CbiQ, CbiO).

  • Isothermal Titration Calorimetry (ITC): Directly measure thermodynamic parameters of binding between CbiN and partner proteins or cobalt ions.

  • Pull-down Assays: Use His-tagged CbiN as bait to identify interacting partners from bacterial lysates, followed by mass spectrometry identification.

In vivo Approaches:

  • Bacterial Two-Hybrid System: Create fusion constructs of CbiN and potential interacting partners with split reporter proteins to detect interactions in a cellular context.

  • FRET/BRET Analysis: Generate fluorescent protein fusions to measure proximity-based energy transfer between CbiN and other components in live cells.

  • Cross-linking Studies: Use chemical cross-linkers with subsequent mass spectrometry to identify proximity relationships in the native membrane environment.

Data Analysis Protocol:

  • Compare binding affinities across different experimental conditions

  • Validate interactions using multiple methodologies

  • Create interaction maps based on strength and specificity of observed interactions

  • Correlate interaction data with functional transport assays

This multi-method approach allows for robust verification of true interactions while minimizing false positives that can occur with any single methodology.

How can machine learning approaches be applied to predict functional domains in CbiN and optimize protein engineering?

Machine learning (ML) approaches offer powerful tools for predicting functional domains in CbiN and optimizing protein engineering efforts:

Prediction of Functional Domains:

  • Sequence-Based ML Models: Train convolutional neural networks on curated datasets of cobalt transport proteins to identify conserved motifs and functional residues in CbiN.

  • Structure-Based Prediction: Apply ML algorithms to predict 3D structural features from sequence data, particularly focusing on transmembrane regions and metal-binding sites.

  • Evolutionary Coupling Analysis: Use co-evolutionary information to predict residue pairs involved in structural contacts or functional interactions .

Optimization for Protein Engineering:

  • Directed Evolution Guidance: ML models can analyze sequence-function relationships to guide mutagenesis efforts toward promising regions of sequence space.

  • Stability Prediction: Employ algorithms that predict the impact of mutations on protein stability, helping researchers avoid destabilizing modifications.

  • Expression Optimization: Use ML to predict optimal codon usage and expression conditions based on the amino acid sequence.

ML ApplicationInput DataOutputValidation Method
Functional domain predictionCbiN sequence alignmentsPredicted binding sitesSite-directed mutagenesis
Structural predictionPrimary sequence3D structural modelCrystallography/cryo-EM
Stability engineeringCandidate mutationsΔΔG predictionsThermal stability assays
Expression optimizationGene sequenceOptimized codonsProtein yield measurement

Recent advances in deep learning, as demonstrated in similar applications with Salmonella Typhimurium, show that these approaches can achieve high accuracy in predicting protein properties without prior exposure to experimental data on the specific protein .

What are the methodological approaches for studying the role of CbiN in Salmonella heidelberg pathogenesis and host interaction?

Studying CbiN's role in Salmonella heidelberg pathogenesis requires sophisticated methodological approaches that bridge molecular microbiology and infection biology:

In vitro Infection Models:

  • Cell Culture Invasion Assays: Compare wild-type and cbiN-deficient S. heidelberg strains for their ability to invade epithelial cells (e.g., Caco-2, HT-29) and survive within macrophages (e.g., RAW264.7, THP-1).

  • Competitive Index Assays: Co-infect cell cultures with wild-type and cbiN mutant strains, then calculate competitive indices to quantify relative fitness.

  • Metal Restriction Studies: Simulate host nutritional immunity by using metal chelators (e.g., calprotectin) and assess bacterial survival.

In vivo Approaches:

  • Animal Infection Models: Use established models (typically mouse or chicken) to compare colonization, persistence, and virulence of wild-type versus cbiN mutants.

  • Organ Burden Analysis: Quantify bacterial loads in relevant organs (intestine, spleen, liver) at defined time points post-infection.

  • Immune Response Profiling: Measure host cytokine production and immune cell recruitment in response to infection with different bacterial strains.

Molecular Mechanistic Studies:

  • Gene Expression Analysis: Use RNA-seq to identify genes differentially expressed in response to cbiN deletion, particularly focusing on virulence factors.

  • Metabolomics: Compare metabolic profiles between wild-type and mutant strains, focusing on B12-dependent pathways.

  • Imaging Techniques: Use fluorescence microscopy with labeled antibodies against CbiN to track protein localization during infection .

These approaches should be implemented with appropriate controls, including complementation strains where the cbiN gene is reintroduced to confirm that observed phenotypes are specifically due to CbiN function rather than polar effects or secondary mutations.

How can researchers address challenges in protein stability and solubility when working with recombinant CbiN protein?

Membrane proteins like CbiN often present significant challenges in terms of stability and solubility. Here are methodological approaches to address these challenges:

Improving Protein Solubility:

  • Fusion Tag Selection: Beyond the standard His-tag, consider fusion partners known to enhance solubility:

    • Maltose-binding protein (MBP)

    • Small ubiquitin-like modifier (SUMO)

    • Thioredoxin (TRX)

    • Glutathione S-transferase (GST)

  • Expression Condition Optimization: Implement a Design of Experiments (DoE) approach to systematically test:

    • Induction temperature (typically lower temperatures of 16-25°C improve solubility)

    • Inducer concentration (lower IPTG concentrations of 0.1-0.5 mM)

    • Cell density at induction (mid-log phase, OD600 of 0.6-0.8)

    • Media composition (supplemented with osmolytes like sorbitol or betaine)

  • Detergent Screening: Test a panel of detergents for extraction and purification:

Detergent ClassExamplesTypical ConcentrationApplications
Non-ionicDDM, OG, Triton X-1001-2% (extraction), 0.1-0.5% (purification)Initial solubilization
ZwitterionicCHAPS, LDAO0.5-2%Intermediate stringency
Facial amphiphilesGlycosides, Peptitergents0.1-1%Gentler extraction
Polymer-basedAmphipols, NanodiscsSystem-dependentStability in solution

Enhancing Protein Stability:

  • Buffer Optimization: Screen various buffer conditions:

    • pH range (typically 7.0-8.5)

    • Salt concentration (150-500 mM NaCl)

    • Addition of stabilizing agents (glycerol 5-20%, trehalose 5-10%)

    • Presence of reducing agents (DTT, β-mercaptoethanol)

  • Directed Mutagenesis: Introduce stability-enhancing mutations based on computational predictions or evolutionary conservation analysis.

  • Co-expression with Partners: Express CbiN together with its natural binding partners (CbiM, CbiQ, CbiO) to form stable complexes.

  • Thermal Shift Assays: Use differential scanning fluorimetry to identify conditions that maximize protein thermal stability .

By implementing these methodologies systematically, researchers can significantly improve both the yield and stability of recombinant CbiN protein, enabling more reliable functional and structural studies.

How does CbiN from Salmonella heidelberg compare to homologous proteins in other bacterial species?

A systematic comparative analysis of CbiN from Salmonella heidelberg with homologous proteins in other bacterial species reveals important evolutionary and functional insights:

Sequence Conservation Analysis:

CbiN proteins are relatively well conserved among enterobacteria, with specific regions showing higher conservation corresponding to functional domains. The N-terminal transmembrane region typically shows higher conservation than the cytoplasmic domains, reflecting evolutionary pressure to maintain membrane association and metal transport function.

Comparative Features of CbiN Proteins:

SpeciesSequence Identity to S. heidelberg CbiNProtein LengthKey Structural DifferencesFunctional Implications
Escherichia coli85-90%93 aaConservative substitutions in transmembrane domainsSimilar function, potentially interchangeable
Klebsiella pneumoniae80-85%93 aaVariations in cytoplasmic loop regionMay affect interaction with CbiQ/CbiO
Yersinia enterocolitica75-80%94 aaExtended C-terminusPossible additional regulatory function
Vibrio cholerae60-65%90 aaDifferent hydrophobicity patternAdapted to different membrane composition
Bacillus subtilis40-45%98 aaDifferent topology predictionGram-positive specific adaptation

Phylogenetic Analysis:

Functional Conservation:

These comparative analyses provide important context for interpreting experimental results with S. heidelberg CbiN and can guide the design of functional studies to explore species-specific adaptations in cobalt transport.

What are common challenges in expression and purification of recombinant CbiN, and how can they be methodologically addressed?

Researchers frequently encounter specific challenges when working with recombinant CbiN. Here are methodological solutions for addressing these issues:

Challenge 1: Low Expression Levels

ProblemPotential CausesMethodological Solutions
Minimal protein detectedToxicity to host cellsUse tight expression control systems (e.g., pET vectors with T7 lysozyme)
Codon usage biasOptimize codons for E. coli or use Rosetta strains with rare tRNAs
Protein instabilityLower induction temperature (16-20°C) and extend expression time (16-24 hours)
Inadequate detectionVerify tag accessibility via Western blot with anti-His antibodies

Challenge 2: Protein Insolubility

ProblemMethodological SolutionsValidation Approach
Protein in inclusion bodiesExpress as fusion with solubility tags (MBP, SUMO)SDS-PAGE analysis of soluble vs. insoluble fractions
Add 0.5-2% mild detergents during lysis (DDM, CHAPS)Detergent screening for optimal solubilization
Use inclusion body solubilization followed by refoldingCircular dichroism to confirm proper folding
Co-express with chaperones (GroEL/ES, DnaK/J)Increased yield in soluble fraction

Challenge 3: Purification Difficulties

  • Poor Binding to Affinity Resin:

    • Ensure the His-tag is accessible and not buried within the protein structure

    • Optimize binding buffer conditions (pH 7.5-8.5 is optimal for His-tag binding)

    • Try alternative affinity tags (Strep-tag II, FLAG tag)

    • Validate tag presence by Western blot before purification attempts

  • Contaminant Co-purification:

    • Implement stringent washing steps with increasing imidazole (20-50 mM)

    • Add secondary purification steps (ion exchange, size exclusion chromatography)

    • Consider on-column cleavage of fusion tags

  • Protein Aggregation During Purification:

    • Maintain detergent above critical micelle concentration throughout purification

    • Add glycerol (10-20%) to all buffers

    • Perform purification at 4°C

    • Consider purification in the presence of stabilizing ligands (cobalt ions)

Validation Methods:

  • Size exclusion chromatography to assess oligomeric state and homogeneity

  • Dynamic light scattering to evaluate sample monodispersity

  • Circular dichroism to confirm secondary structure

  • Thermal shift assays to assess protein stability under different buffer conditions

By systematically addressing these challenges with the described methodological approaches, researchers can significantly improve the yield and quality of recombinant CbiN protein preparations.

How can researchers validate the functional activity of purified recombinant CbiN protein?

Validating the functional activity of purified recombinant CbiN protein is essential to ensure that experimental observations reflect physiologically relevant phenomena. Here are methodological approaches for functional validation:

1. Cobalt Binding Assays:

  • Isothermal Titration Calorimetry (ITC): Directly measure thermodynamic parameters of cobalt binding to purified CbiN.

    • Protocol: Titrate increasing concentrations of CoCl₂ into a solution of purified CbiN while measuring heat changes

    • Data analysis: Calculate dissociation constant (Kd), enthalpy (ΔH), and stoichiometry

  • Equilibrium Dialysis: Determine binding affinity using radiolabeled cobalt (⁵⁷Co or ⁶⁰Co).

    • Protocol: Incubate purified CbiN with labeled cobalt, separate bound from free cobalt by dialysis

    • Quantification: Measure radioactivity in protein chamber versus buffer chamber

  • Fluorescence Quenching: Exploit the intrinsic fluorescence of aromatic residues in CbiN.

    • Protocol: Monitor changes in tryptophan fluorescence upon cobalt binding

    • Analysis: Generate binding curves and calculate dissociation constants

2. Reconstitution into Liposomes:

  • Preparation of Proteoliposomes:

    • Solubilize lipids (typically E. coli polar lipids) in detergent

    • Add purified CbiN at protein:lipid ratio of 1:100 to 1:1000

    • Remove detergent via dialysis or Bio-Beads

  • Transport Assays:

    • Load proteoliposomes with buffer with or without potential energy sources

    • Add radiolabeled cobalt to external buffer

    • Measure accumulation of cobalt inside proteoliposomes over time

    • Compare rates with control liposomes lacking CbiN

3. Complementation Studies:

  • Genetic System:

    • Create a cbiN deletion strain of S. heidelberg or E. coli

    • Verify growth defect under cobalt-limiting conditions

    • Transform with plasmid expressing recombinant CbiN

    • Measure restoration of growth as indicator of functional activity

  • Analysis Parameters:

    • Growth rates in minimal media with defined cobalt concentrations

    • Vitamin B12 production levels

    • Cobalt accumulation in cells

4. Protein-Protein Interaction Assays:

Since CbiN functions as part of a complex, validating interactions with partner proteins provides evidence of proper folding and functionality.

  • Pull-down Assays: Use His-tagged CbiN to capture native CbiM, CbiQ, and CbiO proteins from bacterial lysates

  • Surface Plasmon Resonance: Measure binding kinetics between CbiN and other purified components

  • Cross-linking Studies: Capture transient interactions in native-like environments

Validation Data Interpretation:

AssayPositive ResultNegative ResultPossible Interpretation
Cobalt bindingKd in nM-μM rangeNo binding detectedProtein correctly folded/unfolded
Liposome transportCobalt accumulationNo transport activityFunctional/non-functional in membrane
ComplementationGrowth restorationNo complementationIn vivo functionality/structural issues
Protein interactionsSpecific bindingNo interactionsProper conformation/misfolding

By implementing multiple validation assays, researchers can establish with confidence that their purified recombinant CbiN retains its native biological function .

What are the future research directions for understanding the role of CbiN in bacterial physiology and pathogenesis?

Future research on CbiN in Salmonella heidelberg and related bacteria should focus on several promising directions that will enhance our understanding of both basic bacterial physiology and potential applications in pathogen control:

Structural Biology Approaches:

  • Determination of high-resolution CbiN structure using cryo-electron microscopy or X-ray crystallography

  • Elucidation of the complete CbiMNQO complex architecture to understand the molecular mechanism of cobalt transport

  • Investigation of conformational changes during the transport cycle using techniques like single-molecule FRET

Systems Biology Integration:

  • Multi-omics profiling to understand how cobalt transport systems respond to changing environmental conditions

  • Network analysis to identify regulatory interactions between cobalt transport and virulence factor expression

  • Investigation of metal competition and prioritization mechanisms during infection

Host-Pathogen Interactions:

  • Characterization of how host nutritional immunity affects CbiN function during infection

  • Examination of potential recognition of CbiN by host immune receptors

  • Exploration of CbiN's role in Salmonella survival within different host cell types and tissues

Antimicrobial Development:

  • Evaluation of CbiN as a potential drug target, exploiting its essential role in cobalt acquisition

  • Design of inhibitors that specifically target the CbiMNQO complex

  • Development of attenuated vaccine strains with modified cobalt transport capabilities

Biotechnological Applications:

  • Engineering CbiN for improved cobalt bioaccumulation in bioremediation applications

  • Utilizing CbiN as a component in biosensors for environmental cobalt detection

  • Exploring the potential of modified CbiN as a tool for selective metal delivery in synthetic biology applications

By pursuing these research directions with rigorous methodology and integrative approaches, researchers will gain deeper insights into the fundamental role of CbiN in bacterial physiology while potentially developing new strategies for controlling Salmonella infections and other applications in biotechnology and medicine.

What methodological advances are needed to address current limitations in CbiN research?

Several methodological advances would significantly enhance current research capabilities for studying CbiN and related cobalt transport proteins:

Advanced Imaging Techniques:

  • Development of specific antibodies or nanobodies for super-resolution microscopy of native CbiN localization and dynamics

  • Implementation of correlative light and electron microscopy (CLEM) approaches to visualize CbiN in cellular contexts

  • Application of cryo-electron tomography to visualize the CbiMNQO complex in intact bacterial membranes

Improved Protein Production Methods:

  • Optimization of membrane protein expression systems specifically tailored for small transmembrane proteins like CbiN

  • Development of stabilized cell-free expression systems for direct production of functional CbiN

  • Engineering of specialized detergents or nanodiscs for improved handling of purified CbiN

Enhanced Functional Assays:

  • Development of high-throughput cobalt transport assays to enable large-scale screening

  • Creation of specific fluorescent probes for real-time monitoring of cobalt transport

  • Advancement of single-molecule techniques to study transport kinetics at the individual protein level

Computational Method Development:

  • Improved algorithms for predicting membrane protein structures from limited experimental data

  • Development of specialized force fields for molecular dynamics simulations of metal transport

  • Integration of machine learning approaches to predict metal binding sites with higher accuracy

Genetic Tool Advancement:

  • Development of inducible and tissue-specific gene expression systems for Salmonella

  • Creation of reporter systems specifically designed to monitor metal transport in real-time

  • Refinement of CRISPR-Cas9 techniques for precise genome editing in Salmonella heidelberg

These methodological advances would collectively address current limitations in studying CbiN and advance our understanding of bacterial cobalt transport mechanisms, with potential applications in antimicrobial development and biotechnology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.